Literature DB >> 15351423

Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.

Tána Chrobáková1, Markéta Hermanová, Iva Kroupová, Petr Vondrácek, Tat'ána Maríková, Radim Mazanec, Josef Zámecník, Jan Stanek, Miluse Havlová, Lenka Fajkusová.   

Abstract

Calpain3 (CAPN3, p94) is a muscle-specific nonlysosomal cysteine proteinase. Loss of proteolytic function or change of other properties of this enzyme (such as stability or ability to interact with other muscular proteins) is manifested as limb girdle muscular dystrophy type 2A (LGMD2A, calpainopathy). These pathological changes in properties of calpain3 are caused by mutations in the calpain3 gene. The fact that the human gene for calpain3 is quite long led us to analyse its coding sequence by reverse transcription-PCR followed by sequence analysis. This study reports nine mutations that we found by analysing mRNA of seven unrelated LGMD patients in the Czech Republic. Three of these mutations were novel, not described on the Leiden muscular dystrophy pages so far. Further, we observed a reduction of dysferlin in muscle membrane in five of our seven LGMD2A patients by immunohistochemical analysis of muscle sections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351423     DOI: 10.1016/j.nmd.2004.05.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  18 in total

1.  Identification and characterisation of human dysferlin transcript variants: implications for dysferlin mutational screening and isoforms.

Authors:  Zacharias Aloysius Dwi Pramono; Chin Lai Tan; Irene Ai Lian Seah; Joseph Shean Long See; Siok Yuen Kam; Poh San Lai; Woon Chee Yee
Journal:  Hum Genet       Date:  2009-02-17       Impact factor: 4.132

2.  Novel diagnostic features of dysferlinopathies.

Authors:  Xiomara Q Rosales; Julie M Gastier-Foster; Sarah Lewis; Malik Vinod; Devon L Thrush; Caroline Astbury; Robert Pyatt; Shalini Reshmi; Zarife Sahenk; Jerry R Mendell
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

3.  Dysferlin overexpression in skeletal muscle produces a progressive myopathy.

Authors:  Louise E Glover; Kimberly Newton; Gomathi Krishnan; Roderick Bronson; Alexandra Boyle; Lisa S Krivickas; Robert H Brown
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

4.  Regulation of the M-cadherin-beta-catenin complex by calpain 3 during terminal stages of myogenic differentiation.

Authors:  Irina Kramerova; Elena Kudryashova; Benjamin Wu; Melissa J Spencer
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

5.  Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.

Authors:  L Blázquez; M Azpitarte; A Sáenz; M Goicoechea; D Otaegui; X Ferrer; I Illa; E Gutierrez-Rivas; J J Vilchez; A López de Munain
Journal:  Neurogenetics       Date:  2008-06-19       Impact factor: 2.660

6.  Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle.

Authors:  Irina Kramerova; Elena Kudryashova; Benjamin Wu; Coen Ottenheijm; Henk Granzier; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2008-08-01       Impact factor: 6.150

7.  Identification of a Novel Deep Intronic Mutation in CAPN3 Presenting a Promising Target for Therapeutic Splice Modulation.

Authors:  Ying Hu; Payam Mohassel; Sandra Donkervoort; Pomi Yun; Véronique Bolduc; Daniel Ezzo; Jahannaz Dastgir; Jamie L Marshall; Monkol Lek; Daniel G MacArthur; A Reghan Foley; Carsten G Bönnemann
Journal:  J Neuromuscul Dis       Date:  2019

8.  Novel Missense CAPN3 Mutation Responsible for Adult-Onset Limb Girdle Muscular Dystrophy with Calves Hypertrophy.

Authors:  Sabrine Rekik; Salma Sakka; Sawssan Ben Romdhan; Nouha Farhat; Yasmine Baba Amer; Leila Lehkim; François Jérôme Authier; Chokri Mhiri
Journal:  J Mol Neurosci       Date:  2019-08-13       Impact factor: 3.444

9.  Mutations of CAPN3 in Korean patients with limb-girdle muscular dystrophy.

Authors:  Jin-Hong Shin; Hyang-Suk Kim; Chang-Hoon Lee; Cheol-Min Kim; Kyu-Hyun Park; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

10.  How to tackle the diagnosis of limb-girdle muscular dystrophy 2A.

Authors:  Marina Fanin; Anna Chiara Nascimbeni; Elisabetta Tasca; Corrado Angelini
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.